NCT03616353 (IMPACTS) is a EARLY_PHASE1 clinical trial of Perineural Hydrodissection in Carpal Tunnel Syndrome, sponsored by Leslie Witton.

Who is sponsoring NCT03616353?

NCT03616353 is sponsored by Leslie Witton.

What drugs are being tested in NCT03616353?

Interventions in NCT03616353: Perineural Hydrodissection, Corticosteroid Injection.

What condition does NCT03616353 study?

NCT03616353 studies Carpal Tunnel Syndrome.

Is NCT03616353 still recruiting?

NCT03616353 is currently status unknown. Last updated 9 August 2019.

Last reviewed 2019-08-09 · How we verify

NCT03616353: IMPACTS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IMpact of Perineural Hydrodissection Over Alternative Therapies in Patients With Carpal Tunnel Syndrome

Status unknown EARLY_PHASE1 Last updated 9 August 2019

What this trial tests

EARLY_PHASE1 trial testing Perineural Hydrodissection in Carpal Tunnel Syndrome in 60 participants. Status unknown.

Timeline

15 October 2018

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Leslie Witton
Phase	EARLY_PHASE1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	15 October 2018
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	1 location across Canada

Drugs / interventions tested

Perineural Hydrodissection
Corticosteroid Injection

Conditions studied

Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Leslie Witton

Who can join

18 and older, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multidisciplinary, single-blinded, three-arm randomized controlled trial, comparing perineural hydrodissection and steroid injection for the treatment of CTS. Patients are screened based on pre-established eligibility criteria and randomized to one of the three study groups. Patients are followed at 6-week, 3-month, 6-month, and 12-month time points to assess the primary and secondary outcomes of the study, which include both patient-reported outcome measures and objective clinical assessments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03616353 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leslie Witton
Last refreshed: 9 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03616353.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing